Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemia.

Ann Hematol · 2013 · PMC3701796 · PMID 23616009

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

showed a trendp = 0.057so close (0.05 < p ≤ 0.1)

ITD + CR patients showed a trend towards lower frequencies of terminal myeloid DCs (mDC1, p = 0.057; mDC2, p = 0.0912) in comparison to HD (Fig. 3b ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.